The clinical update offers a concise overview of recently published, high-impact journal articles that may influence clinical practice, summarized for our readers. This edition highlights recent studies related to the diagnosis and management of osteoporosis. It reviews essential international guidelines on the clinical use of trabecular bone score (TBS) and a goal-oriented approach to treatment, alongside emerging data on the cardiovascular safety of romosozumab and evidence underscoring the underuse of zoledronate. In particular, it discusses the limited utilization of zoledronate in early postmenopausal women and its inpatient use in older adults after hip fractures.
Sung et al. (Mon,) studied this question.